Candel Therapeutics Inc
CADL
Get informed when a big investor buys or sells
+ FollowMarket Cap$858.73M
Close$
$2.22
81.5% downside
Current Fair Value
81.5% downsideOvervalued by 81.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $858.73 Million |
|---|---|
| Enterprise Value | $706.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.72 |
| Beta | -0.5 |
| Outstanding Shares | 74,131,229 |
Return
| Return on Equity | -37.87% |
|---|---|
| Return on Assets | -22.95% |
| Return on Invested Capital | -30.56% |
Valuation & Multiples
| P/E Ratio | -8.31 |
|---|---|
| PEG | -1.17 |
| Price to Sales | - |
| Price to Book Ratio | 12.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.83 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3799▲ 3.40% |
|---|---|
| Total Calls | 371,700▲ 36.20% |
| Total Puts | 141,200▲ 49.58% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 69.64%▲ 25.01% |
|---|---|
| Total Invested | $212.92M▲ 59.48% |
| Investors Holding | 118▲ 30.00% |
ESG Score
No data
About Candel Therapeutics Inc
2,021 employees